Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform

  • Arun Sharma
  • , Caleb Marceau
  • , Ryoko Hamaguchi
  • , Paul W. Burridge
  • , Kuppusamy Rajarajan
  • , Jared M. Churko
  • , Haodi Wu
  • , Karim I. Sallam
  • , Elena Matsa
  • , Anthony C. Sturzu
  • , Yonglu Che
  • , Antje Ebert
  • , Sebastian Diecke
  • , Ping Liang
  • , Kristy Red-Horse
  • , Jan E. Carette
  • , Sean M. Wu
  • , Joseph C. Wu

Research output: Contribution to journalArticlepeer-review

Abstract

RATIONALE:: Viral myocarditis is a life-threatening illness that may lead to heart failure or cardiac arrhythmias. A major causative agent for viral myocarditis is the B3 strain of coxsackievirus, a positive-sense RNA enterovirus. However, human cardiac tissues are difficult to procure in sufficient enough quantities for studying the mechanisms of cardiac-specific viral infection. OBJECTIVE:: This study examined whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) could be used to model the pathogenic processes of coxsackievirus-induced viral myocarditis and to screen antiviral therapeutics for efficacy. METHODS AND RESULTS:: hiPSC-CMs were infected with a luciferase-expressing coxsackievirus B3 strain (CVB3-Luc). Brightfield microscopy, immunofluorescence, and calcium imaging were used to characterize virally infected hiPSC-CMs for alterations in cellular morphology and calcium handling. Viral proliferation in hiPSC-CMs was quantified using bioluminescence imaging. Antiviral compounds including interferonβ1, ribavirin, pyrrolidine dithiocarbamate, and fluoxetine were tested for their capacity to abrogate CVB3-Luc proliferation in hiPSC-CMs in vitro. The ability of these compounds to reduce CVB3-Luc proliferation in hiPSC-CMs was consistent with reported drug effects in previous studies. Mechanistic analyses via gene expression profiling of hiPSC-CMs infected with CVB3-Luc revealed an activation of viral RNA and protein clearance pathways after interferonβ1 treatment. CONCLUSIONS:: This study demonstrates that hiPSC-CMs express the coxsackievirus and adenovirus receptor, are susceptible to coxsackievirus infection, and can be used to predict antiviral drug efficacy. Our results suggest that the hiPSC-CM/CVB3-Luc assay is a sensitive platform that can screen novel antiviral therapeutics for their effectiveness in a high-throughput fashion.

Original languageEnglish
Pages (from-to)556-566
Number of pages11
JournalCirculation Research
Volume115
Issue number6
DOIs
Publication statusPublished - 29 Aug 2014
Externally publishedYes

Keywords

  • cardiac
  • myocarditis
  • myocytes
  • stem cells

Fingerprint

Dive into the research topics of 'Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform'. Together they form a unique fingerprint.

Cite this